Funded with Support from

It is important to identify amblyopia at a young age. The new blinq pediatric vision screener is designed to detect microstrabismus, thereby increasing screening sensitivity for amblyopia.

In this presentation from Pediatric Ophthalmology Subspecialty Day 2022, Dr. Evelyn Paysse discusses why refractive surgery is a reasonable treatment for severe refractive error in children with amblyopia who do not respond to standard therapy.

In this presentation from Pediatric Ophthalmology Subspecialty Day 2022, Dr. Michael Repka discusses digital therapeutics, a new class of software-driven interventions intended to treat various medical conditions.

Recommendations distilled from the PPPs for the evaluation and management of amblyopia, esotropia, and exotropia

In this clinical pearl, Dr. David Wallace addresses the common problem of parents confusing the difference between strabismus and amblyopia and the treatment options available for each.

In this interview from AAO 2022, Pediatric Ophthalmology Subspecialty Day co-chair Dr. David Wallace provides his top highlights from the meeting.

A prospective observational study evaluated the prevalence of anisometropia in children with congenital nasolacrimal duct obstruction and assessed amblyopia risk in this population.

In this presentation from Pediatric Ophthalmology Subspecialty Day 2021, a panel of researchers shares current clinical studies that will affect the future of pediatric ophthalmology.

Investigators compared improvements in visual outcomes between glasses treatment and no treatment in children with moderate bilateral astigmatism and normal vision.